TipRanks on MSN

Pfizer’s Protonix pediatric study completion: What investors should watch next

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer (PFE) is running a Phase 2 study titled “AN ...
TipRanks on MSN

MapLight’s phase 2 Alzheimer’s psychosis trial marks a key milestone for MPLT investors

MapLight Therapeutics, Inc. ($MPLT) announced an update on their ongoing clinical study. MapLight Therapeutics Advances Mid-Stage Trial for ...

Final, 247th participant randomized and commences treatment in Actinogen’s XanaMIA pivotal phase 2b/3 Alzheimer’s trial

Topline final safety and efficacy results for the full 36 weeks of treatment from all participants will be available in ...
The New England Journal of Medicine

Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors. Its dose–response relationships with respect to side effects ...